Ibrahim Irshat, Nuermaimaiti Yilimire, Maimaituxun Gulijianaiti, Luo Xinling, Maimaituxun Mailudemu, Akbar Azimat, Tuerxun Kahaer, Wu Yuanquan
Department of General Surgery, The First People's Hospital of Kashi Prefecture, Kashi, 844000, China.
Department of Endocrinology, The First People's Hospital of Kashi Prefecture, Kashi, 844000, China.
Diabetes Ther. 2024 Jun;15(6):1333-1348. doi: 10.1007/s13300-024-01579-6. Epub 2024 Apr 15.
The prevalence of diabetes mellitus and its sequelae has been on the rise, and diabetic foot ulcer (DFU) is the leading cause of non-traumatic lower limb amputation globally. The rising occurrence and financial burden associated with DFU necessitate improved clinical assessment and treatment. Diabetes has been found to enhance the formation of neutrophil extracellular traps (NETs) by neutrophils, and excessive NETs have been implicated in tissue damage and impaired wound healing. However, there is as yet insufficient evidence to clarify the value of NETs in assessing and predicting outcomes of DFU.
We designed this prospective study with three cohorts formed from type 2 diabetes mellitus (T2DM) patients with DFU (n = 200), newly diagnosed T2DM patients (n = 42), and healthy donors (n = 38). Serum levels of NETs were detected for all groups, and the prognostic value for DFU-related amputation was analyzed.
The results showed that serum NET levels of the DFU group were significantly higher than in the T2DM group (P < 0.05), which also had significantly elevated serum NET levels compared to healthy donors (P < 0.05). Multivariate Cox regression showed that serum NET levels, diabetic foot surgical history, and Wagner grade were the risk factors for amputation (P < 0.05), and these three variables also exhibited the highest coefficient values in additional Lasso Cox regression. For patients with DFU, Kaplan-Meier curves showed that high serum NET levels associated with higher amputation probability (HR = 0.19, P < 0.01) and ROC curve based on NET value showed good validity for amputation (AUC: 0.727, CI 0.651-0.803).
Elevated serum NET levels serve as an easily accessible serological prognostic marker for assessing the risk of DFU-related amputation, thereby offering evaluation metrics for healthcare providers. Further investigations are necessary to understand the mechanisms driving this relationship.
糖尿病及其后遗症的患病率一直在上升,糖尿病足溃疡(DFU)是全球非创伤性下肢截肢的主要原因。DFU发生率的上升及其带来的经济负担使得改善临床评估和治疗成为必要。研究发现,糖尿病会增强中性粒细胞形成中性粒细胞胞外陷阱(NETs),过多的NETs与组织损伤和伤口愈合受损有关。然而,目前尚无足够证据阐明NETs在评估和预测DFU结局中的价值。
我们设计了这项前瞻性研究,由患有DFU的2型糖尿病(T2DM)患者(n = 200)、新诊断的T2DM患者(n = 42)和健康供者(n = 38)组成三个队列。检测所有组的血清NETs水平,并分析其对DFU相关截肢的预后价值。
结果显示,DFU组的血清NET水平显著高于T2DM组(P < 0.05),T2DM组的血清NET水平也显著高于健康供者(P < 0.05)。多因素Cox回归显示,血清NET水平、糖尿病足手术史和瓦格纳分级是截肢的危险因素(P < 0.05),这三个变量在附加的套索Cox回归中也显示出最高的系数值。对于DFU患者,Kaplan-Meier曲线显示,高血清NET水平与更高的截肢概率相关(HR = 0.19,P < 0.01),基于NET值的ROC曲线对截肢显示出良好的有效性(AUC:0.727,CI 0.651 - 0.803)。
血清NET水平升高是评估DFU相关截肢风险的一种易于获取的血清学预后标志物,从而为医疗保健提供者提供了评估指标。有必要进一步研究以了解驱动这种关系的机制。